The utility of standardized advance directives: the general practitioners’ perspective by unknown
SCIENTIFIC CONTRIBUTION
The utility of standardized advance directives: the general
practitioners’ perspective
Ina Carola Otte1,2 • Bernice Elger1 • Corinna Jung2 • Klaus Walter Bally2,3
Published online: 9 February 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Advance directives (AD) are written docu-
ments that give patients the opportunity to communicate
their preferences regarding treatments they do or do not
want to receive in case they become unable to make
decisions. Commonly used pre-printed forms have differ-
ent formats. Some offer space for patients to (a) appoint a
surrogate decision maker, and/or (b) to determine future
medical treatments and/or (c) give a statement of personal
values. So far it is unknown which forms GPs preferably
use and why they decide to do so. 23 semi-structured
interviews with GPs were analysed using content analysis.
Interviewees mainly use short templates (to appoint sur-
rogate decision makers) and medium length templates with
checkboxes to indicate patients’ preferences in regards to
life prolonging measures. Especially when patients faced
the progression of a disease, participants use the latter
version. Only then, the interviewees remarked, patients are
capable to rate concrete situations reliably. GPs also realize
the importance of the verbal assessment of patients’ pref-
erences; however they rarely keep a written form of the
conversation. Some GPs hand out one or more templates
and ask their patients to read and think about them at home
with the option to talk to them about it later on, while
others prefer their patients to fill them out alone at home.
Regardless of template usage, most GPs emphasize that
ADs require regular updates. GPs tend to see standardized
advance directives mainly as a tool to start a conversation
with their patients and to identify their real preferences and
values. When the patient is still not facing the progression
of an already existing disease it could be sufficient to only
appoint a surrogate decision maker instead of creating a
full AD. However, in all other situations, appointing a
surrogate decision maker should be backed up by a written
statement of a patient’s general values. Patients and their
relatives should always have the opportunity to ask their
GP for medical advice when drafting an AD. It is crucial to
regularly verify and update existing ADs within the course
of a disease.
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Advance directives (AD) are written documents that give
patients the opportunity to communicate their preferences
regarding treatments they do or do not want to receive in
case they become unable to make decisions. ADs also often
offer space for patients to (a) appoint a surrogate decision
maker, (b) determine future medical treatments and/or
(c) give a personal statement. ADs are most useful for
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treating physicians, patients, and their relatives when they
are drafted in a clear, understandable, and not too broad
manner, simultaneously covering all important and relevant
medical information (Johnson et al. 2015).
The process to draft such an AD can be very time-
consuming, especially for older patients (Lum et al. 2015).
Nevertheless, general practitioners (GPs) are good candi-
dates to achieve the desired level of quality in ADs since
they often treat their patients in a holistic way and for an
extended period of time (Leal Hernandez et al. 2015;
Harringer 2012). In practice however, studies show that
GPs often use standardized forms assisting patients in
drawing up an AD. Unfortunately, individual statements of
any given patient rarely are added to these forms (Har-
ringer 2012; Nauck et al. 2014). The existing body of lit-
erature highlights several limitations of ADs that are linked
to this phenomenon. Short forms (often used only to
appoint a surrogate decision maker) increase the likelihood
of excluding patients’ wishes to prolong or determine
therapy (Shalowitz et al. 2006; Coppolino and Ackerson
2001). Furthermore, Pautex et al. (2015) found, that
patients expect their relatives to play an active role in
future medical decision making, but often do not share
specific wishes and preferences with them.
Also, the accuracy of healthy patients’ stated prefer-
ences regarding future treatment choices varies (Nauck
et al. 2014; Shalowitz et al. 2006). The content, structure,
and underlying attitude of standard forms can influence
patients, depending on their source; for example, forms
provided by the Catholic Church as compared to those
from ‘right-to-die’ organizations (Nauck et al. 2014;
Kressel et al. 2007).
Studies also show that the practical use of these tem-
plates is often limited by various factors, such as the usage
of statements that are too general in nature (Voltz et al.
1998; Porensky and Carpenter 2008; Burchardi et al. 2005;
Hobbs 2007).
In Switzerland, the 2013 adult protection law strength-
ens the legal status of ADs. Different organisations [for
example the Swiss Medical Association FMH, Caritas,
ethics consultation services (Dialog Ethik) as well as right-
to-die- organizations (Exit)] offer pre-printed templates to
facilitate the process of generating an AD. In general, three
different types of templates are currently in use. The
shortest version of the available templates only allows
patients to appoint a person as a surrogate decision maker
(Evans et al. 2012; Robertson 1995). The version of
medium length uses checkboxes to assess patients’ values
with a special focus on life-sustaining treatments and the
discontinuation of therapy. The longest version offers
additional space to write individual statements.
GPs often emphasize the importance of individual
anamneses of a patient’s values (Otte et al. 2014) and
patients often come to their GP to draft an AD (Ashby et al.
1995). We therefore seek to better understand the process
of drawing up ADs in general practice. Up until now, no
qualitative data exists, explaining which standardized
templates GPs use and for what reasons.
Our qualitative study is the first to elaborate on whether
GPs use standardized templates, and if so, which version,
why, and whether they change/add a patient’s individual
explanations to the forms. Our study also sheds light on
potential concerns and shortcomings related to the use of
templates as well as barriers GPs encounter when assisting
their patients in drawing up ADs.
Methods
This paper references results from a nation-wide study
entitled ‘‘Conditions and Quality of End-of-Life Care in
Switzerland—the role of general practitioners,’’ which was
funded by the Swiss National Science Foundation. The aim
of this study is to conduct a detailed exploration of the
functions of general practitioners, who administer pallia-
tive care in primary practice. Twenty-three qualitative
interviews with general practitioners were conducted and
analysed.
Sampling and data collection
To obtain a diverse selection of physicians working in
different practice settings (group versus single), regions
(different cantons, rural versus urban region etc.), gender,
age, and professional experience, 30 general practitioners
were purposively selected from the FMH (Swiss Medical
Association) list (proportional quota sampling). Partici-
pants were contacted via e-mail outlining the research. Of
this sample, 23 physicians agreed to participate (positive
respond rate of 76 %). In a 1 h face-to-face interview in
their practices, participants answered questions about
administering palliative care in a primary care setting. No
one other than the interviewers and the interviewee was
present during the interview. The qualitative semi-struc-
tured interview guideline consisted of 20 questions. The
interviewer started with a broader question about the
importance of ADs in GPs daily work. Then the GP was
asked, which patients are usually interested in drafting an
AD and about GPs experiences how ADs are usually
drafted? If a GP mentioned the use of a template he was
asked which template and why. Also the GP was asked,
who (the patient or the GP) usually starts a conversation
about ADs and what GPs feel to be the best moment to start
talking about the topic of ADs. The interviews were
recorded from December 2012 to February 2013. Partici-
pants were asked about administering palliative care, their
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networking with other institutions and stakeholders, and
the meaning of ADs for their work. Additional questions
explored when and how they approached this latter topic
with their patients. The interview guide was pilot tested
and subsequently adapted during the first interviews. Either
IO or CJ conducted the interviews in German. Both are
sociologists who have long term experience with qualita-
tive methods. An additional interviewer (with training in
qualitative methods) was hired to conduct the French
interviews. All interviews were transcribed verbatim in the
original language of the interviewees (French and several
Swiss German dialects) and were analysed with the support
of the analysis programme atlas.ti, Version 7.0. Partici-
pants were given the opportunity to review their interview
transcripts. However, no participant made use of this
option.
Analysis
All four authors (of varying disciplinary background:
sociology, general practice, palliative care) analysed the
anonymised transcripts. Everyone followed Mayring’s nine
steps of content analysis (Mayring 2015): (1) relevant data
was defined, (2) context and appearance of the data was
registered, (3) a formal characterization of the data material
was described, (4) course of analysis was specified, (5) a
theory-lead differentiation was checked, (6) technique of
analysis was defined (summarization, explication, struc-
turing), (7) unit of analysis was defined, (8) data material
was analysed, and (9) finally interpreted. The data was
repeatedly coded, moving from concrete passages to a
more abstract level of coding. Themes were derived from
the data found in repeating concepts. In team meetings, all
findings were critically tested and discussed by all coders.
Any disagreements were solved by discussion. Theoretical
saturation was reached when interviewees repeated prior
findings and did not add anything of new significance.
The study was approved by Basel Ethics Committee (Nr.
EK 248/12) prior to its initiation. All participants provided
their informed consent.
Results
When questioned about the role of ADs in their daily work,
the great majority of those interviewed in our study agree
that an AD is of high importance and very useful for their
work. According to them, more and more patients ask for
assistance in making an AD. GPs frequently report finding
ADs to be important because they make it possible to start
a conversation about end of life (EOL) issues with their
patients. Interviewees often use standardized AD forms
that vary in length. The shortest form offers the possibility
to appoint a surrogate decision maker while the longest
form, additionally offers space for an individual statement
from the patient. Templates are mainly completed by the
patient at home, without the GP.
Why do Swiss GPs use standardized AD forms?
The long duration of time with which Swiss GPs see their
patients not only serves as the foundation of trust in the
relationship, but can at times be a communication barrier.
Some interviewees found it difficult to initiate conversa-
tions about emotional and sensitive topics with their
patients, especially when the patients already suffer from a
severe illness:
[GP 2] The patient was mentally always very fit and I
knew him for quite a while. I really had some
doubts and constraints talking to him about
ADs
According to interviewees, the available templates are a
helpful instrument for them to start conversations on end of
life questions whereby the GP can then assess wishes and
values of patients:
[GP 7] So, to me it (the AD) is basically a starter and a
reminder that we have discussed this topic with
the patients. It gives me a frame and room to
talk about it; it (the template) is something
official that I can use to talk about these topics
[GP 6] So, I use it to verbally explore patients’ wishes
and having a short template makes leading such
a conversation much easier for me
[GP 8] Advance directives are helpful to start a
conversation not only between doctor and
patient but also between patient and involved
relatives. It is also easier for me to assess a
patient’s values during the conversation, where
the patient has the possibility to ask questions;
so I can get a feeling for a patient’s values. So I
think I actually use it more as an instrument to
verbally assess patient’s future treatment
wishes. For me, having a template for advance
directives makes the start of this conversation
much easier.
How begins a conversation about ADs und what
kinds of templates are used?
The way a GP starts a conversation on the topic of ADs can
influence the quality of it. Some GPs hand out one or more
templates and ask their patients to read and think about
them at home with the option to talk to them about it later
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on, while others prefer their patients to fill them out alone
at home. Other GPs assess and document patients’ prefer-
ences in more than one consultation, sometimes even
together with a patient’s relatives.
[GP 5] Patients sometimes ask me, ‘‘Do you have an
AD that I can sign?’’ and I do have different
templates, which I hand out in this case. I tell
them to think about the content, do they feel
that it covers all important topics? Or do they
disagree with some parts? And if they feel the
template suits them, we usually sign it together
the next time we see each other
[GP 1] I cannot tell my patients what to do or what not
to do, I tell them their possibilities and options
and then I tell them to discuss it with their
family and to document it as good as possible,
what they would want later on and what not.
1. Short standardized AD forms are mainly used to
appoint a surrogate decision maker.
Some of the interviewees use the shortest version of the
available templates mainly to name a surrogate decision
maker, since they find it difficult for patients to anticipate
future hypothetical scenarios. Another reason participants
choose to use the shortest version is to avoid the burden of
talking about ‘‘terminal scenarios.’’
[GP 8] My experience is that most of my patients
prefer the shortest version possible, where they
only name a surrogate decision maker
[GP 4] …and that is the thing, you cannot cover every
eventuality in an AD that is way too
complicated and impossible to achieve. And as
slong as you’re healthy you simply don’t need a
special document, you can simply take the
short official version of the Swiss Medical
Association FMH. But as soon as things
change, you need to reconsider this choice
[GP 9] So, I use 2 templates, the shorter one (to name a
surrogate decision maker) and the longer
version, which I only offer if the patients
explicitly want it. But these scenarios that the
longer version includes are so hypothetical; in
my opinion it barely makes sense to use that one
[GP 7] In general, using an AD with the intent to
alleviate pain is in my opinion okay; however,
talking about PEG-tubes, enteral nutrition and
resuscitation with my patient is difficult for me.
I mainly use it to appoint a surrogate decision
maker
GP 11 uses the shortest form because the template is only a
tool for him to start a conversation in which he can assess a
patient’s wishes, needs, and values.
[GP 11] The paper is not important, it is important that
you get to know the patient. So I use the
shortest version as a starter, but the real
assessment of patients’ wishes takes place
during the conversation we have.
2. Standardized AD templates, which offer the possibility
for the patient to express his/her wishes regarding
future life-prolonging treatments.
A few participants use the medium length version in
which patients can, in addition to naming a surrogate
decision maker, express their wishes regarding life pro-
longing treatments by ticking off checkboxes. However,
GPs tend to refrain from offering these templates to healthy
patients. Instead, GPs mainly offer versions that provide
patients the possibility to either accept or decline the use of
a PEG tube or antibiotics and/or resuscitation to those with
a serious condition.
Their reason for this trend is that GPs often fear that
patients cannot realistically imagine future scenarios, such
as swallowing inability after a stroke. The more detailed
versions allow GPs to address concrete situations and to
add changes to the AD if necessary.
[GP 11] And if I fill in an AD with my patients, I always
advise them to make a lot of changes to the
form, because especially the medium form
includes so many situations that are highly
hypothetical and very abstract, it does not make
any sense to fill it in
[GP 10] Well, so there is a form from the FMH, it is
very short and here is a longer form. So the
medium one, I always use that for the patients,
but I find these situations very broad and often
too far away from reality, so I see no sense in
that
[GP 8] As long as a patient is still healthy, the short
form is sufficient, but as soon as a serious
illness progresses it is useful to have a longer
version which determines if in case of a
pneumonia he/she’d like to receive antibiotics
or not.
3. Standardized templates paired with individual
anamneses:
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Many GPs emphasize the importance of assessing
individual values of their patients in order to correctly
ascertain their future treatment wishes. However, partici-
pants are not definitive as to whether they also keep a
written form of these additional individual anamneses.
[GP 3] Sometimes patients ask me why they should
have an AD. Why is it important to have one?
And then I tell them that it is important for me,
so we can talk about it and I can understand
their thoughts on different things and so I know
what they would want in case they cannot
express their wishes any longer
[GP 6] So ADs are a tool for a patient to express his/
her wishes in situations where he/she is left
unable to communicate them. But they also
help me before these situations occur, because I
get the possibility to talk about potential
questions and therefore assess a patient’s
values and wishes. So it is a great tool which
makes it easy to start this conversation and to
assess his/her values during it
[GP 9] For me it is important to get to know the
thoughts of a patient. What are his/her attitudes
regarding different options and how are his/her
attitudes/preferences different than mine? So
we can find a compromise, something we agree
on
[GP 19] All right, well I am going to be very
provocative. Advance directives are very useful
when we discuss them with the patient…
Advance directives are an issue where I am
going to take 1 or 2 h and sometimes more than
one conversation, in order to discuss this topic
with my patients… I do it with sick patients in
order to find out what are their wishes and in
order to try to understand how (.) they imagine
future things. However, the problem with
advance directives is, when we do it with
patients who are still healthy, is that they are
not able to imagine future illness
Regardless of the template GPs use, most emphasize that
ADs are legally binding documents, which require regular
updates.
[GP 3] I find it important that my patients start
thinking about questions related to future
treatment decisions and I also have to say since
ADs are a legally binding document we have to
update them regularly, so they are still valid
later on … but the process of thinking about
topics related to ADs is something, that I
always support in my patients
[GP 6] Well, as soon as a patient’s situation changes, I
man, maybe a disease that is progressing or
cancer and the prognosis changes as well, then
we could adapt the existing AD to make it fit
the new situation. And that is the main topic to
me, as soon as someone becomes seriously ill,
… ‘‘We made an AD 2 years ago, what do you
think, what would you like in case for example
you’re suffering from dyspnea? Should we give
you antibiotics in case of an pneumonia or just
morphine? We need to talk about these things,
no?’’
Discussion
For most GPs in this study, ADs are an important tool to start
a conversation about difficult topics, such as approaching
death or death itself. According to the participants of this
study, the assessment of the personal values of the patient
during this conversation weighs more than the written AD in
the end. Often they use either the short (only surrogate
decision maker) or the medium length version (surrogate
decision maker and check boxes concerning future medical
treatment) of the available templates. However, most feel
that the situations described in the latter version are highly
hypothetical. Although interviewed GPs mentioned the
existence of the longest version, which consists of an indi-
vidually written statement, they do not actively use it.
For the medium length version, interviewees stated
concerns that, in their opinion, pre-printed forms are too
hypothetical to cover all important aspects and therefore
offer space for misunderstandings and misinterpretation.
This fear of misunderstandings is in line with results of a
qualitative study by Thompson et al., where participant
hospital physicians and nursing professionals note the
possible negative effects of advance directives, such as the
risk of misinterpretation or general errors in treatment
(under- or paradoxical overtreatment) (Thompson et al.
2003). Nevertheless, Harringer’s study from (2012) shows
that GPs—despite all concerns—often use short to medium
length forms for ADs. Some of our interviewees explicitly
claim that it is not the form, but the conversation itself that
matters to them. Under this approach, the final document
(which they think is too hypothetical anyway) seems to
lose some of its importance, while the focus clearly lies on
the verbal anamneses of patient’s values. Emanuel et al.
(1995) note the importance of verbal anamneses. Recent
studies elaborate on other efforts to further support patients
in light of the common issues experienced during end of
life scenarios in non-confrontational settings. For example,
different approaches can be utilized in conjunction with the
go wish card game (Lankarani-Fard et al. 2010).
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Furthermore, the guidelines of the SAMS (Swiss
Academy of Medical Sciences) regarding medical com-
munication indicate the low value of short and standardized
advance directives (Schweizerische Akademie der Medi-
zinischen Wissenschaften 2013). Based on these guideli-
nes, standardized advance directives cannot express
individual values because standardized sentences cannot
sufficiently illustrate a patient’s health and/or biographical
background (Schweizerische Akademie der Medizinischen
Wissenschaften 2013; Lack 2008). Broad statements such
as wanting to ‘‘maintain dignity’’ or be ‘‘free from pain’’,
are often too general to provide a basis for individual
treatment decisions (Coppola et al. 2001; Lo and Stein-
brook 2004). For example, ADs often refer to forgoing an
intervention when the patient’s condition is ‘‘irreversible’’
or ‘‘terminal’’. However, determining whether patients are
in these states is often very difficult (Sudore and Fried
2010).
Additionally, broad statements increase the possibility
of contradictions with patients’ stated wishes (Lack 2008).
Individuality of an AD is therefore often considered as one
of the main indicators of quality (Lack 2008). Patients’
treatment preferences and values change as their health
changes (Halpern and Arnold 2008; Loewenstein 2005;
Koch 2001), at the end of life (Fried et al. 2007), and even
during periods of stable health (Fried et al. 2007). GPs in
this study shared their concern over making ADs with
patients who are still healthy because they fear patients
would not be able to consistently anticipate future scenar-
ios and treatment preferences. This is in line with the
results of Bauer (2009).
Since an AD is a legal document, stated wishes must be
as authentic as possible and include specific wording to
avoid possible misunderstandings. Regular updates are
therefore of the utmost importance. The Swiss Academy of
Medical Sciences (SAMS) guidelines recommend that ADs
should be part of a process, which spans more than one
conversation to assess and update values, treatment goals,
and possible proxies. However, our interviewees rarely
mentioned updates. Interviewees reported offering follow
up conversations (as recommended by the SAMS) only
when the patient actively asked for it.
Interviewed GPs use the shortest template mainly to
start a conversation and appoint surrogate decision makers.
However, when the appointment of a surrogate is often the
only written document in the end, it is questionable whe-
ther the surrogate’s decisions are congruent with the
patient’s wishes. Shalowitz et al. (2006) found that patient-
designated surrogates incorrectly predict patients’ end-of-
life treatment preferences in one third of cases. Also
patients’ fears of abuse by relatives and possible surrogates
is a factor that can limit the employment of an AD (Sahm
et al. 2005). Following the example set by one of the GPs
(GP 8), it can be sufficient to use only the short form to
appoint a surrogate decision maker during a patient’s
healthy days; however, as soon as a serious disease pro-
gresses, a more detailed version should be used to offer the
patient space to document personal values and preferences
as well as anticipated decisions for the future (Evans et al.
2012).
According to our results, patients often complete an AD
template at home, without the support of their GP. This can
lead to various difficulties and inaccuracies that can com-
promise the quality of an AD (Nauck et al. 2014; Spoelhof
and Elliott 2012). In order to avoid possible inaccuracies,
drafting a useful AD usually takes a few consultations,
which also provides the patient time to ask questions.
Further, since there is a pool of different forms for ADs
from which to draw (from religious organizations as well
as from right-to-die organizations), the one a GP hands out
can insinuate certain choices for the patient and therefore
influence the patients’ follow up decisions. Moreover,
while the idea to elaborate patient’s values during the
conversation could be a good start for assessment, the
information a patient receives might not be sufficient for
him/her to complete an AD at home. Patients often feel
ambivalent about different treatment options and therefore
need support and help with their decision making (Frost
et al. 2011). Modifiable factors such as knowledge gaps,
uncertainty regarding outcomes, lack of clarity about what
matters most, and feeling pressured to choose a particular
option may exacerbate the decisional conflict and make the
support of the treating GP essential (Murray et al. 2009).
Conclusions
Standardized advance directives are important tools for
GPs and offer a good basis for them to start a conversation
about patients’ preferences and future treatment wishes.
When the patient is still not facing the progression of an
already existing disease it could be sufficient to only
appoint a surrogate decision maker instead of creating a
full AD, since preferences often change during the course
of illness.
However, in all other situations, the appointing of a
surrogate decision maker should be supported with a
written statement of the patient’s general values. In order to
avoid broad and general statements, tools such as the go
wish card game with a variety of pre-formulated value
attitudes could be helpful.
Patients and their relatives should always have the
opportunity to ask their GP for medical advice when
drafting an AD.
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It is crucial to regularly verify and update existing ADs
within the course of a disease.
Strengths and limitations
A clear strength of this study is the use of a qualitative
method to explore a multifaceted topic, in which GPs could
express how they integrate advance directives in their
practice.
Since our study is a qualitative study we are not able to
reach a conclusion regarding the quantitative aspects and
distributions of opinions among GPs.
Furthermore, because our results rely solely on quali-
tative data, triangulation from other methods of data col-
lection, such as a survey, may increase the validity of the
results. For this reason, the next step of our study is a large-
scale questionnaire to quantify the results that we obtained
from our interviews.
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